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Introduction
Confusions and inconsistencies persist in the liter-
ature with regard to operational deﬁnitions of
critical change points in the course of a major
depressive episode, such as remission, recovery,
relapse and recurrence. It was the US NIMH
Collaborative Depression Study (CDS), a land-
mark long-term cohort study of patients with
mood disorder, that ﬁrst operationalized remission
as a state with no more than one or two mild
depressive criterion symptoms, and recovery as
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Objective: Consensus operational deﬁnitions for symptomatic
remission and recovery of a major depressive episode have been
proposed but only irregularly followed.
Method: We examined the predictive validity of diﬀerent deﬁnitions of
recovery in a multi-center 10-year follow-up study of an inception
cohort of untreated unipolar major depressive episodes (n =9 5 ) .T i m e
to recovery and time to recurrence after recovery were estimated by
Kaplan–Meier survival analyses for alternative deﬁnitions requiring 2,
4, 6 or 12 months of remission to declare recovery.
Results: The median time to recovery was 3.0, 4.0, 4.0 and 12.0 months
respectively. The index episode lasted longer than 24 months in 9.4%,
9.2%, 12.6% and 24.5%. The median time to subthreshold recurrence
was 16.0, 32.0, 42.0 and 74.0 months.
Conclusion: Either 4- or 6-month duration of remission deﬁned a
change point before which the episode was continuous and after which
the recurrence was reasonably unlikely.
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Significant outcomes
• Requiring two months of remission is probably too short to declare recovery because a subthreshold
recurrence occurs in more than half of the cohort within a year and a half.
• If we require 4 or 6 months before we declare recovery, the median time to recovery is 4 months and
that to subthreshold recurrence is nearly 3 years.
• Requiring 12 months of remission before declaring recovery would make the episode discontinuous
yet long and inﬂate the rate of chronicity.
Limitations
• The sample size was relatively small and the conﬁdence intervals were accordingly wide.
• This was a naturalistic study and the treatments were not controlled.
• Validity of alternative deﬁnitions of remission requires a separate study.
Re-use of this article is permitted in accordance with the
Creative Commons Deed, Attribution 2.5, which does not
permit commercial exploitation.
Acta Psychiatr Scand 2008: 117: 35–40
All rights reserved
DOI: 10.1111/j.1600-0447.2007.01119.x
Copyright   2007 The Authors
Journal Compilation   2007 Blackwell Munksgaard
ACTA PSYCHIATRICA
SCANDINAVICA
35eight or more weeks of remission (1). Some have
followed this convention (2–5), while others have
not (6–9). But none of these studies has provided
empirical examination of the validity of competing
deﬁnitions.
With regard to the oﬃcial diagnostic criteria,
the deﬁnitions in DSM-IV are in line with the
CDS deﬁnitions because they declare recovery if
full remission, which is deﬁned as a period of at
least 2 months in which there are not signiﬁcant
symptoms of mania or depression, is attained
between two mood episodes (10). The ICD-10
also appears to follow this tradition when it
requires at least 2 months free from any signif-
icant mood symptoms for depressive disorder to
be recurrent (11). On the other hand, the DSM-
III-R was somewhat aberrant because it required
no signiﬁcant signs or symptoms of the distur-
bance for at least 6 months for an episode to be
in full remission, while requiring 2 months of
return to more or less usual functioning for the
disorder to be recurrent (12). The DSM-III did
not have any explicit deﬁnitions for recurrence or
remission (13).
This state of confusion is unfortunate not only
for the psychiatric sciences because then ﬁndings
cannot be compared and accumulated, but also for
the psychiatric services because then the literature
cannot inform the practitioners about how to judge
recovery and declare the end of continuation
treatment or about whether to recommend main-
tenance treatment based on knowledge of likeli-
hood of recurrence.
It is important to note that, in this framework
for long-term treatment of depression (14, 15),
emphasis is placed on the symptomatic aspects of
the course of a major depressive episode. This is in
line with recent deﬁnitions of remission in psy-
chotic disorders (16, 17) and anxiety disorders (18).
However, there is growing tendency, especially
with regard to schizophrenia and other serious
mental disorders, to use the term recovery in
conjunction with quality and meaning of life in
spite of continued symptoms (19). Whether we
need to include functional or even broader nor-
malization in the deﬁnition of recovery with regard
to depression is being discussed and researched
(20), but in this article, we follow the symptoma-
tological orientation currently adopted in the
mood disorder section of the DSM-IV (10) and
ICD-10 (11).
Aims of the study
The present article therefore sets out to examine
the diﬀerential predictive validity of the compet-
ing deﬁnitions of symptomatic recovery. We
propose that a more valid deﬁnition of recovery
should deﬁne a change point until which the
syndrome is relatively continuous, but after which
a return of the syndrome will become reasonably
unlikely.
Material and methods
Data for this report come from the Group for
Longitudinal Aﬀective Disorders Study (GLADS),
described in detail elsewhere (5, 21). Brieﬂy, it is a
multi-center collaborative naturalistic study of
patients with heretofore untreated mood episodes
who had presented to various psychiatric facilities
all over Japan.
The 23 collaborating centers included psychi-
atric departments of 13 university hospitals and
six general hospitals, three mental hospitals and
one community mental health center. Participat-
ing psychiatrists at each center administered a
semi-structured interview, called the Psychiatric
Initial Screening for Aﬀective Disorders (PISA)
(22) to a representative subset of its ﬁrst-visit
patients to ascertain the patients eligibility. The
details of the predetermined rules on how to
select a subset of ﬁrst-visit patients were left to
individual centers, depending on their human and
logistic resources: some centers administered
PISA to all their ﬁrst-visit patients, others did
so with those on a certain day of the week and
still others did so with those seen by one or two
collaborating psychiatrists only. The eligibility
criteria were: i) depressive state or manic state; ii)
having received no antidepressant or antipsy-
chotic medication in the preceding 3 months; iii)
aged 18 years or older; and iv) absence of
conditions that would render detailed psycho-
pathological assessment diﬃcult. Out of all the
eligible subjects, each participating center was
expected to enter the ﬁrst such patient every 1 or
2 months.
The study protocol was approved by the Ethics
Committee of the National Center of Neurology
and Psychiatry, Japan, as well as those of the
participating centers. Written informed consent
was obtained from all participants after full
disclosure of the purposes and procedures of the
study. The patients eligible for and consenting to
the study were then interviewed within 1 week of
entry by a psychiatrist using the entry version of
the Comprehensive Assessment List for Aﬀective
Disorders (COALA) (23). The COALA consists
of a series of semi-structured interviews that
enable serial assessment of the cohort; these
include the entry version, monthly follow-up
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follow-up version. The reliability of the PISA and
COALA has been reported to be good to excel-
lent (24). The cohort was followed up monthly
until treatment termination, 6-monthly thereafter
up to 2 years and then annually up to 10 years.
At each assessment, the course of the illness was
recorded for each month of the survey period in
ﬁve grades of 5 = above diagnostic threshold for
major depressive episode, 4 = between 5 and 3,
3 = asymptomatic or minimally symptomatic
with at most two of nine diagnostic criteria
symptoms of at most mild degree, 2 = between
3 and 1 and 1 = above diagnostic threshold for
manic episode.
The present paper focuses on the course of the
subset of the cohort who were diagnosed with
major depressive disorder according to DSM-IV
(10). We deﬁned remission in accordance with the
NIMH CDS as a state with no more than one or
two mild criterion depressive symptoms (2). The
CDS then deﬁned recovery as consecutive two
months of remission. Once recovery was declared,
patients were considered to have fallen into a new
mood episode (recurrence) when they met the
DSM-IV criteria for major depressive episode,
manic episode or hypomanic episode. In addition,
if they did not yet meet the criteria for a major
depressive episode but had more than two symp-
toms or had only one or two symptoms that were
graver than mild degree for a month, they were
considered to have fallen into a subthreshold
depressive episode. The duration of the well
interval was counted after the end of the period
required for judging recovery.
The CDS deﬁnition of recovery by 2 months of
remission has been criticized for being too short
(25, 26) and the consensus deﬁnitions proposed
alternative deﬁnitions of recovery by 4 or 6 months
of remission. The present paper examines the
predictive validity of alternative duration require-
ments of 2, 4, 6 and 12 months of remission to
deﬁne recovery. We hypothesized that a more valid
deﬁnition of duration required for declaring recov-
ery would:
i) not prolong the duration of the index episode
too much, lest the episode contains too long
well periods in itself;
ii) not increase the rates of chronicity (never
attaining recovery) too much, lest we give an
overly pessimistic impression that depression
is a chronic or incurable disease;
iii) ensure that the time to recurrence is reason-
ably long, so that recovery once declared can
assure the patients that a return of symptoms
is reasonably unlikely.
We used the spss for Windows 11.5 (27) to
perform Kaplan–Meier analyses to depict survival
curves of the major depressive episodes.
Results
A total of 1853 patients were screened at 23
participating centers between December 1992 and
December 1995. A total of 466 patients suﬀered
from broadly deﬁned mood disorders, but either
failed to meet the other entry criteria or declined
consent and 126 entered the study. Of these, 95 met
the DSM-IV criteria for major depressive disorder,
either single episode (n = 67, 71%) or recurrent
(n = 28, 29%). Fifty-six subjects (59%) were
females, and the mean age was 44.3 (SD 15.2).
The mean score for the 17-item Hamilton Rating
Scale for Depression was 19.9 (SD 8.6) and 14
(15%) were inpatients upon study entry. The major
depressive episode was superimposed on pre-exist-
ing dysthymia in ﬁve (5%). The median length of
episode before study entry was 3.0 months (range:
0.5–48.0).
Table 1 gives the median duration of the index
episode and rates of chronicity at 12, 24, 60 and
120 months, depending on the numbers of months
of remission required to declare recovery. The table
also gives the median time to recurrence of a full
episode or a subthreshold episode after recovery
Table 1. Outcomes of major depressive episodes for different definitions of recovery
Definition of recovery
Follow-up rate
(%)
Median duration of
index episode (months)
Rates of chronicity (%) Median length of well interval (months)
12-month 24-month 60-month 120-month
Until full episode
recurrence
Until subthreshold
recurrence
2 months of remission 90.5 3.0 (2.3–3.7) 16.4 9.4 5.4 3.6 103 17.0 (1.9–32.1)
4 months of remission 89.5 4.0 (2.9–5.1) 21.9 9.2 6.2 4.1 >101 32.0 (1.6–62.4)
6 months of remission 88.4 4.0 (2.2–5.8) 29.9 12.6 6.3 4.2 113 (62–164) 47.0 (10.4–83.6)
12 months of remission 82.1 12.0 (7.9–16.1) 46.0 24.5 12.7 5.1 97 74.0
Numbers in parentheses represent 95% confidence intervals.
95% confidence intervals could not be calculated.
The cumulative rate of relapse at the latest follow-up of 112 months was 53.2%, so that the median can be estimated to be close to 120.
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37was declared, according to each proposed deﬁni-
tion.
We illustrate the actual numbers of patients
reaching each critical change points or being lost
before reaching one in the case of the operational
deﬁnition of recovery requiring 6 months of remis-
sion. Of the original cohort of 95 patients, 84
patients reached recovery so deﬁned, 10 patients
were lost to follow-up before reaching recovery
and one never experienced recovery over the entire
120 months of follow-up. Of these 84 who were
judged recovered, 10 never had a recurrence until
the end of the 120-month follow-up, 29 experi-
enced a full episode recurrence, additional 11
experienced a subthreshold recurrence and one
presented with a manic episode, 33 were lost to
follow-up without ever recording any of these
events. Because this was a naturalistic follow-up
study and the treatment was not controlled,
around the time of recovery, the patients were
receiving on average 45.1 (SD 64.7, IQR 0–60)
mg ⁄day of imipramine equivalent and only 16
(19%) were on >75 mg ⁄day.
Discussion
This is the ﬁrst study to examine the predictive
validity of diﬀerent duration requirements of
remission to achieve recovery in terms of the
length of the index episode, rates of chronicity and
the succeeding well interval until recurrence, based
on a long-term naturalistic follow-up data. We
found that diﬀerent deﬁnitions can give up to
fourfold diﬀerences in estimates of episode length
and time to subthreshold recurrence but not in
time to full recurrence.
Several recent studies have shown that sub-
threshold depression is associated with psychoso-
cial disability and more severe future course of the
illness and requires treatment (28, 29). A system-
atic review of continuing antidepressant treatment
after acute phase treatment reported a consistent
relative risk reduction of about 50% in relapse
rates up to 3 years (30). For a representative
patient in our cohort, then, even if recovery is
achieved after 2 months of remission, continuing
adequate antidepressant treatment for 1½ years
would reduce the subthreshold recurrence rates
from 50% to 25%; an average patient may then
very well wish to stay on medication. On the
other hand, if recovery is declared after 4 or
6 months of remission, one needs to be on
medication for 3–4 years to reduce the subthresh-
old recurrence rates from 50% to 25%; many if
not all the patients may choose to stop the
medication.
Given our hypotheses regarding the predictive
validity of the operational deﬁnition of recovery,
requiring 12 months would include so much well
time before recovery is declared as to draw an
unnecessarily chronic picture for the index episode.
Requiring only 2 months, on the other hand,
would devaluate the signiﬁcance of recovery
because half of the patients so declared would
experience a subthreshold recurrence within
1½ years. It is noteworthy that the time to full
recurrence remained constant at about 100 months
for the three deﬁnitions examined. However, given
the clinical signiﬁcance of subthreshold depression
noted above, requiring 4- to 6-month remission
before declaring recovery appears to be a reason-
able deﬁnition, as it would not make the index
episode unnecessarily chronic, yet assures a rela-
tively low likelihood of subthreshold recurrence
once recovery is declared and can provide some
indication for ensuing treatments.
There are some possible weaknesses of the
present study. First, the sample size was relatively
small and 95% conﬁdence intervals were some-
times incalculable or very wide, especially with
regard to time to full episode recurrence. This may
partly explain the apparent lack of diﬀerentiation
among various deﬁnitions of recovery with regard
to this variable. Secondly, this was a naturalistic
study, in which we did not control the treatment,
and the amount of treatment, actually provided
was very low. During the continuation phase, 43%
were not receiving any antidepressant therapy and
a further 37% were on inadequate treatment with
<75 mg ⁄day of imipramine equivalent or
<600 mg ⁄day of lithium. Six months later,
during the maintenance phase, the corresponding
ﬁgures were 50% and 29% (31). Thirdly, our
cohort consisted mainly of ﬁrst episode patients
and with less severe symptomatology, and this may
have inﬂuenced estimates of time to recurrence and
may be another reason for lack of diﬀerence in
times to full episode recurrence among various
deﬁnitions of recovery that we examined. However,
Cox regression analyses did not reveal statistically
signiﬁcant inﬂuence of recurrent vs. single episode
in the median durations of the index episode or the
median lengths of the ensuing well intervals. It
would be interesting to see analyses similar to ours
with the data available from other long-term
studies of more severe, recurrent cohorts. Finally,
we could not examine the inﬂuence of diﬀerent
deﬁnitions of remission. One study clearly pointed
to the importance of this deﬁnition because diﬀer-
ent symptomatological cut-oﬀs to deﬁne remission
resulted in an almost sevenfold increase in the
length of a depressive episode (32). There are also
Furukawa et al.
38arguments for including more than symptomatic
criteria to deﬁne remission (33). These problems
need separate examination.
The greatest strength of the current study, on the
other hand, is the high follow-up rates achieved
through serial assessments of a prospective cohort
for 10 years. Some drop-outs were inevitable and
we adjusted for the censored cases through survival
analyses. The current DSM-IV follows the NIMH
CDS tradition and requires 2 months of no signif-
icant signs or symptoms of the disturbance before
declaring full remission. The naturalistic follow-
up data given in the present report along with the
functional and prognostic signiﬁcance of sub-
threshold depression demonstrated in cross-sec-
tional and longitudinal studies (28), and the
experimental treatment data summarized in the
meta-analysis (30) warrant reconsideration of
the consensus deﬁnitions of remission, recovery,
relapse and recurrence in major depression for the
upcoming DSM-V.
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